Arcadia Biosciences, Inc. (RKDA) Stock Forecast
RKDA analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $12.00 average of analyst targets
- Upside to target
- +7,172.7% from the latest close
- Next earnings
- November 6, 2026
- 52-week range
- $0.17 – $4.92
RKDA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
RKDA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$2.42 | −$2.42 | −$2.42 | −$2.56 | +5.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
RKDA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $7.7M | $7.7M | $7.7M | +29.3% | 1 |
RKDA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
RKDA revenue: reported and forecast
RKDA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$2.35 | −$2.35 | −$2.35 | −$2.35 | −$2.42 | +3.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
RKDA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; RKDA beat in 5 of 10.
What analysts expect from RKDA
The average price target is $12.00, 7,172.7% above the latest close of $0.17. For 2026 the average estimate is −$2.42 per share on revenue of $7.7 million. Arcadia Biosciences beat the EPS estimate in 5 of the last 10 quarters.
Related: RKDA income statement, RKDA key metrics, RKDA chart. See the RKDA stock overview for the latest quote and news.
RKDA forecast FAQ
What is Arcadia Biosciences's price target?
The average analyst price target for Arcadia Biosciences is $12.00, 7,172.7% above the latest close of $0.17.
When does Arcadia Biosciences report earnings?
Arcadia Biosciences is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
Does Arcadia Biosciences usually beat earnings estimates?
Arcadia Biosciences reported EPS at or above the analyst estimate in 5 of the last 10 quarters.